BPC-157
Pentadecapeptide / Gastric Origin
A synthetic pentadecapeptide consisting of 15 amino acids, derived from a protective protein identified in gastric juice, with extensive indexed literature on systemic activity.
PubMed Literature Index
255
studies indexed in the public literature
as of May 9, 2026 · view PubMed search ↗
Body Protection Compound-157 (BPC-157) is a synthetic pentadecapeptide derived from a protein identified in gastric juice. First described by Sikiric et al. (1993), the compound has been the subject of preclinical investigation across multiple research domains.
The indexed literature describes activity observed in structural systems, vascular systems, and epithelial systems. Research has explored molecular signaling pathways including nitric oxide system modulation and FAK-paxillin signaling cascade dynamics (Seiwerth et al., 2018).
BPC-157 has been characterized as chemically stable across varying pH environments. Its molecular structure consists of 15 amino acids with a defined sequence that has been synthesized and studied independently by multiple research groups (Chang et al., 2011).
Initially characterized in the early 1990s at the University of Zagreb, BPC-157 was isolated as a fragment of a larger protective protein found in gastric juice. The designation 'Body Protection Compound' was applied by the original research group based on observed cytoprotective properties in preclinical models.
The body of published literature has expanded from initial gastric system investigations to encompass structural, vascular, epithelial, and neurological system research. Over three decades, multiple independent laboratories have contributed to the indexed literature base.
Activity has been observed in structural, vascular, and epithelial systems in preclinical models. Reports in the indexed literature describe properties related to extracellular matrix integrity, angiogenic processes, and nitric oxide system modulation.
Molecular signaling investigations have identified pathway interactions including FAK-paxillin dynamics and VEGF-related cascades. These findings have been reported across multiple independent research groups and preclinical model systems.
- Structural system integrity and extracellular matrix modulation
- Angiogenesis and vascular formation pathways
- Nitric oxide system dynamics
- Cytoprotective activity in epithelial systems
- FAK-paxillin signaling cascade interactions
- Cellular proliferation pathway research
- Sikiric P, et al. (1993). "Stable gastric pentadecapeptide BPC 157." Journal of Physiology - Paris. [PubMed]
- Seiwerth S, et al. (2018). "BPC 157 and standard angiogenic growth factors." Current Pharmaceutical Design. [PubMed]
- Chang CH, et al. (2011). "The promoting effect of pentadecapeptide BPC 157." Life Sciences. [PubMed]
- Cerovecki T, et al. (2010). "Pentadecapeptide BPC 157 in ligament healing." Journal of Orthopaedic Research. [PubMed]
- Tkalcevic VI, et al. (2007). "Enhancement of colonic anastomosis healing." Journal of Pharmacological Sciences. [PubMed]
Size
Pricing is available to verified members.
- 99%+ Purity — Batch Testing Program
- Certificate of Analysis Available
- Ships from Rockwall, TX
- For Research Use Only
Materials referenced on this page are intended for laboratory research purposes. No claims regarding therapeutic efficacy are made or implied.